S100B and Alzheimer disease: In a transgenic mouse model of Alzheimer’s disease, overexpression of S100B resulted in increased Aβ deposits, enhanced astrocytosis and microgliosis, and higher levels of pro-inflammatory cytokines, when compared to control mice [210].